Belite Bio to Host Webcast on November 14, 2023, to Discuss Third Quarter 2023 Financial Results
November 07 2023 - 8:00AM
Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage
biopharmaceutical drug development company focused on advancing
novel therapeutics targeting degenerative retinal diseases that
have significant unmet medical needs, today announced that it will
host a webcast on Tuesday, November 14, 2023, at 4:30 p.m. Eastern
Time to discuss the Company’s financial results for the third
quarter ended September 30, 2023, and provide a general business
update.
Webcast
InformationDate: Tuesday, November 14,
2023 Time: 4:30 p.m. Eastern Time (1:30 p.m.
Pacific Time)Webcast Link:
https://wsw.com/webcast/cc/blte/1366794
Webcast Link InstructionsYou
can join the live webcast by visiting the link above or the
“Presentations & Events” section of the Company’s Investor
Relations website
at https://investors.belitebio.com/presentations-events/events.
A replay will be available for approximately 90 days after the
event.
About Belite Bio
Belite Bio is a clinical-stage biopharmaceutical
drug development company focused on advancing novel therapeutics
targeting degenerative retinal diseases that have significant unmet
medical needs, such as Stargardt disease and geographic atrophy in
advanced dry age-elated macular degeneration, in addition to
specific metabolic diseases. For more information, follow us on
Twitter, Instagram, LinkedIn, Facebook, or visit us at
www.belitebio.com.
Media and Investor Relations
Contact:Jennifer Wu ir@belitebio.com
Julie Fallonbelite@argotpartners.com
Belite Bio (NASDAQ:BLTE)
Historical Stock Chart
From Apr 2024 to May 2024
Belite Bio (NASDAQ:BLTE)
Historical Stock Chart
From May 2023 to May 2024